dr. james c. yao on everolimus in pancreatic neuroendocrine tumors
Published 11 years ago • 217 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
2:01
dr. james yao on everolimus in advanced pancreatic neuroendocrine tumors
-
5:52
everolimus in pancreatic neuroendocrine tumors and carcinoid tumors
-
7:29
ecc 2015: radiant-4 trial showed promise in the treatment of neuroendocrine tumours
-
3:35
everolimus in pancreatic neuroendocrine tumors
-
4:38
everolimus and sunitinib in pancreatic neuroendocrine tumors
-
3:39
targeted therapies in neuroendocrine tumors
-
0:52
dr. yao discusses unanswered questions regarding the treatment of pancreatic nets
-
24:37
what causes alzheimer's disease: amyloid vs tau
-
54:27
jc: phase 3 trial of cabozantinib to treat advanced nec 15-10-24
-
59:20
inside the issue: optimizing the diagnosis and treatment of neuroendocrine tumors
-
1:36
dr. james yao discusses the investigation of biomarkers in neuroendocrine tumors
-
3:33
radiant-3 trial: everolimus in pancreatic neuroendocrine tumors
-
14:47
debate: does everolimus have a role in carcinoid tumors? - yes
-
1:35
dr. yao on takeaways from the radiant-3 trial
-
7:08
sequencing considerations in advanced pancreatic neuroendocrine tumors
-
3:05
the genetics behind familial neuroendocrine tumors
-
3:20
emerging therapies in neuroendocrine tumors (nets)
-
37:26
1. nets overview, james yao, md; md anderson, 2018 houston conference
-
3:16
neuroendocrine tumors: goals of therapy with somatostatin analogs
-
5:28
prognostic indicators in pancreatic neuroendocrine tumors
-
4:39
using sunitinib in pancreatic neuroendocrine tumors (pnets)
-
6:52
neuroendocrine tumors: disease factors influencing the initial treatment approach